Cantor Fitzgerald reiterated its 'overweight' rating on Oracle stock on June 11, 2026.
2 reports, 1 independent
Updated Oct 23
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald reiterated its 'overweight' rating on Oracle stock on June 11, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.ISI expressed debt concerns while Cantor Fitzgerald reaffirmed its rating on Oracle.1 source
Cantor Fitzgerald reiterated 'overweight' rating on Oracle stock.1 source
Keep exploring
The entities involved
-
Oracle
company in Madrid, Spain
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Nyxoah SA was listed on the Nasdaq exchange, and Cantor Fitzgerald reiterated an overweight rating on the company.
- Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.
- Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.